首页> 外文期刊>Journal of Physiology and Pathophysiology >Evaluation of the cytoprotective effects of anti-ulcer agents in acid-alcohol induced gastric ulceration in wistar rats
【24h】

Evaluation of the cytoprotective effects of anti-ulcer agents in acid-alcohol induced gastric ulceration in wistar rats

机译:Wistar大鼠抗溃疡剂在酸酒精诱导的胃溃疡中的细胞保护作用评估

获取原文
           

摘要

Adequate studies have been done using proton pump inhibitors and H2-receptor antagonist and only few studies for cyto-protective and gastric acid secretions have been done in Nigeria. Therefore this work studied the cyto-protective and gastric acid secretory effects of rabeprazole, ranitidine, omeprazole and cimetidine in wistar rats. 28 male wistar rats of weights 300 to 400 g were recruited and randomly divided into seven experimental groups of 4 rats each. Ulcers were induced via oral administration of a mixture acid alcohol (Ethanol and HCl). Group A: Ulcer alone; Group B: 20 mg/kg Rabeprazole + Ulcer; Group C: 20 mg/kg Rabeprazole + 20 mg/kg Ranitidine + Ulcer. Group D: Normal control group received clean drinking water ad libitium. Group E: 20 mg/kg Omeprazole + Ulcer. Group F: 20 mg/kg ranitidine + ulcer. Group G: 100 mg/kg cimetidine + ulcer. At the end of the treatment and induction, volume of gastric acid secreted, pH values, Ulcer index, stomach and body weights were analyzed statistically. There were significant decrease (P<0.05) in the volume of gastric acid secreted for the groups that received the ranitidine and rabeprazole compared to group A (ulcer alone). The pH values of the groups that received the proton pump inhibitors were neutralized at the end of the experiment which shows a better cyto-protective effects of the drugs and there were significant differences (P<0.05) among those groups E, F and G compared to group A. The animals with lesser stomach weights have more ulcers index compared to those with higher stomach weights. This research showed that groups treated with a combination of rabeprazole and ranitidine has a better potency for the management of gastric ulcer patients.
机译:使用质子泵抑制剂和H2受体拮抗剂已经进行了充分的研究,在尼日利亚,只有很少的细胞保护和胃酸分泌研究。因此,这项工作研究了雷贝拉唑,雷尼替丁,奥美拉唑和西咪替丁对wistar大鼠的细胞保护作用和胃酸分泌作用。招募28只体重为300至400g的雄性wistar大鼠,并将其随机分为七个实验组,每组4只大鼠。通过口服混合酸乙醇(乙醇和HCl)诱发溃疡。 A组:仅溃疡; B组:20 mg / kg雷贝拉唑+溃疡; C组:20mg / kg雷贝拉唑+ 20mg / kg雷尼替丁+溃疡。 D组:正常对照组自由饮水。 E组:20 mg / kg奥美拉唑+溃疡。 F组:20mg / kg雷尼替丁+溃疡。 G组:100 mg / kg西咪替丁+溃疡。在治疗和诱导结束时,对胃酸分泌量,pH值,溃疡指数,胃和体重进行统计分析。与A组(单独溃疡)相比,接受雷尼替丁和雷贝拉唑治疗的组的胃酸分泌量显着减少(P <0.05)。在实验结束时中和接受质子泵抑制剂的各组的pH值,这表明该药物具有更好的细胞保护作用,并且与之相比,E,F和G各组之间存在显着差异(P <0.05)胃重量较小的动物与胃重量较大的动物相比,溃疡指数更高。这项研究表明,雷贝拉唑和雷尼替丁联合治疗的组对胃溃疡患者的治疗效果更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号